title: Properties of [3H]bunazosin binding in rat kidney.
abstract: Properties of alpha 1-adrenoceptor binding in the renal cortex of rats were studied with [3H]bunazosin as the radiolabeled ligand. Both temperature and incubation time influenced bunazosin receptor binding. Subcellular distribution of [3H]-bunazosin binding revealed that the membrane fraction (30,000 x g pellet) had the largest proportion of total binding sites. Pretreatment of membrane preparation at 56 degrees C for 30 minutes greatly decreased the specific binding of [3H]-bunazosin, though there was no significant effect of the pretreatment at 24 degrees C and 37 degrees C for 30 minutes. Among various cations, some divalent ions such as Cu++ and Zn++ greatly decreased bunazosin binding, whereas monovalent ions had no effect on specific binding. Results of Scatchard analysis suggested that the rat renal cortex membrane has single binding sites with an apparent dissociation constant of 0.38 +/- 0.06 nmol/L, though the rat medulla membrane has no potent binding activity with bunazosin. The displacement study revealed that various adrenergic agents inhibit [3H]bunazosin binding in dose-dependent fashion; the rank order of potencies was bunazosin prazosin > phentolamine >> dl-norepinephrine > clonidine, yohimbine >> pindolol, propranolol. These findings reveal that bunazosin has specific receptor binding in the rat renal cortex, indicating that alpha 1-adrenoceptors exist in the rat renal cortex.
authors.affiliation: Okayama University Medical School, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Ogura
authors.forename: E
authors.initials: E
authors.lastname: Katayama
authors.forename: T
authors.initials: T
authors.lastname: Mitsui
authors.forename: K
authors.initials: K
authors.lastname: Takatori
authors.forename: Z
authors.initials: Z
authors.lastname: Ota
authors.forename: K
authors.initials: K
authors.lastname: Mizukawa
authors.forename: N
authors.initials: N
authors.lastname: Ogawa
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000378:metabolism* / Q000493:pharmacokinetics; D000818:Animals; D002412:Cations / Q000494:pharmacology; D006358:Hot Temperature; D007668:Kidney / Q000378:metabolism* / Q000648:ultrastructure; D007672:Kidney Cortex / Q000378:metabolism / Q000648:ultrastructure; D007700:Kinetics; D008297:Male; D008566:Membranes / Q000378:metabolism; D011799:Quinazolines / Q000378:metabolism* / Q000493:pharmacokinetics; D051381:Rats; D017208:Rats, Wistar; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism; D018340:Receptors, Adrenergic, alpha-1; D013347:Subcellular Fractions / Q000378:metabolism; D014018:Tissue Distribution; D014316:Tritium
chemical_list: D000317:Adrenergic alpha-Antagonists; D002412:Cations; D011799:Quinazolines; D011942:Receptors, Adrenergic, alpha; D018340:Receptors, Adrenergic, alpha-1; D014316:Tritium; C018176:bunazosin